Obesity Gets Some Respect (ARNA) (VVUS) (OREX)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/4/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Equities close higher as softer jobs data quiets rate-hike expectations
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
Bill for Medicare Coverage, AMA Designation Positive for Obesity Drug Makers (ARNA) (VVUS) (OREX) - Leerink Swann
June 19, 2013 12:23 PM EDTLeerink Swann analyst Marko Kozul made positive comments on obesity drug makers Arena Pharmaceuticals (NASDAQ: ARNA), VIVUS (NASDAQ: VVUS) and Orexigen (NASDAQ: OREX) intra-day Wednesday, saying he sees meaningful trends developing in... More
